Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.
Diagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple Sclerosis.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Recommendations for the management of multiple sclerosis relapses.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Targeting IRF4 in autoimmune diseases.
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
MAIT cells in autoimmunity.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Relationships Between Retinal Axonal and Neuronal Measures and Global Central Nervous System Pathology in Multiple Sclerosis.
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
Central and Peripheral Nervous System Demyelination Following Mycoplasma Pneumonia Infection With Review of Literature.
Importance of Rookshana Karma (dehydrating therapy) in the management of transverse myelitis.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
The autonomic balance predicts cardiac responses after the first dose of fingolimod.
Emerging roles of exosomes in neuron-glia communication.
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Alteration of CD1 expression in multiple sclerosis.
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »